Clinical Trial Detail

NCT ID NCT02671955
Title A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Janssen Research & Development, LLC
Indications

head and neck cancer

pancreatic cancer

lung small cell carcinoma

non-small cell lung carcinoma

colorectal cancer

cervical cancer

Advanced Solid Tumor

Therapies

JNJ-61610588

Age Groups: adult

No variant requirements are available.